Compare MNKD & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNKD | ESTA |
|---|---|---|
| Founded | 1991 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2004 | 2018 |
| Metric | MNKD | ESTA |
|---|---|---|
| Price | $2.35 | $59.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $8.64 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 8.0M | 493.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.67 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $348,966,000.00 | $61,208,000.00 |
| Revenue This Year | $35.81 | $28.04 |
| Revenue Next Year | $11.89 | $26.23 |
| P/E Ratio | $114.00 | ★ N/A |
| Revenue Growth | 22.23 | ★ 76.49 |
| 52 Week Low | $2.25 | $26.56 |
| 52 Week High | $6.51 | $83.31 |
| Indicator | MNKD | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 21.52 | 31.84 |
| Support Level | N/A | $36.41 |
| Resistance Level | $6.18 | $68.38 |
| Average True Range (ATR) | 0.14 | 3.20 |
| MACD | 0.05 | -0.80 |
| Stochastic Oscillator | 17.19 | 29.91 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.